PerAF-based resting-state fMRI classifier for minimal hepatic encephalopathy

Yunli Zhang1,2, Zhai Huang1, Bin Qin3

  • 1Department of Intensive Care Unit, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Frontiers in Neurology
|September 11, 2025
PubMed
Abstract

Insights

Percentage amplitude of low frequency fluctuation (PerAF) shows promise for diagnosing minimal hepatic encephalopathy (MHE). This neuroimaging marker aids in the early identification of cognitive impairment in liver cirrhosis patients.

Area of Science:

  • Neuroimaging
  • Medical Diagnostics
  • Biomarker Discovery

Background:

  • Minimal hepatic encephalopathy (MHE) is a prevalent cognitive impairment in patients with end-stage liver cirrhosis.
  • Accurate diagnosis of MHE is challenging due to the lack of sensitive biomarkers and reliable diagnostic methods.
  • Understanding abnormal spontaneous brain activity is crucial for MHE diagnosis.

Purpose of the Study:

  • To investigate abnormal spontaneous brain activity in MHE patients.
  • To evaluate the diagnostic value of four neuroimaging indicators (ALFF, fALFF, PerAF, ReHo) for MHE using Support Vector Machine (SVM).
  • To identify potential biomarkers for early MHE detection.

Main Methods:

  • Recruited 45 MHE patients and 40 healthy controls.
  • Measured local spontaneous brain activity using Amplitude of Low Frequency Fluctuation (ALFF), Fractional Amplitude of Low Frequency Fluctuation (fALFF), Percentage Amplitude of Low Frequency Fluctuation (PerAF), and Regional Homogeneity (ReHo).
  • Employed SVM analysis to build a classification model and assess diagnostic efficacy.

Main Results:

  • MHE patients showed decreased ALFF in specific brain regions (AUC=0.75) and decreased ReHo (AUC=0.72).
  • fALFF metrics demonstrated limited classification performance (AUC < 0.70).
  • Decreased PerAF in specific frontal and parietal regions achieved high accuracy (AUC=0.83, accuracy=81.18%), outperforming other metrics.

Conclusions:

  • Decreased mean PerAF in the right supramarginal gyrus, right dorsolateral superior frontal gyrus, and right middle frontal gyrus are potential neuroimaging indicators for MHE.
  • These findings provide critical evidence for developing clinical screening protocols for early MHE identification.
  • PerAF serves as a promising biomarker for early cognitive impairment detection in MHE patients.